TABLE 5.

Other suggestions from 136 HCPs on NCDP policy.

Suggestions	Number of HCPs
Ⅰ The efficacy and safety of centralized-purchased medicines need to be guaranteed.	42
Ⅱ Drug prices should be set scientifically, and reasonable profit margins should be retained for enterprises to encourage them to develop and improve innovative drugs.	19
Ⅲ Improve the choice freedom of original research drugs or centralized-purchased drugs.	26
Ⅳ The medical insurance catalogue need update with the centralized-purchased drugs catalogue, and the medical insurance payment standards need to be optimized.	6
Ⅴ The salary of medical staff and the level of hospital information construction should be ameliorated.	12
Ⅵ Varieties of centralized-purchased drugs need to be further optimized.	19
Ⅶ Strengthen the propaganda of consistent evaluation generic drugs and NCDP policy, and increase the recognition of medical staff and patients in centralized-purchased drugs.	8
Ⅷ Optimize the procurement methods, time, and supply channels of the drugs.	12